FRANKFURT (Reuters) – Qiagen (DE:QIA) said its non-executive Chairman Hakan Bjoerklund had resigned with immediate effect after the genetic testing company’s shareholders rejected an improved takeover offer from Thermo Fisher (N:TMO).
Qiagen board member Lawrence Rosen, the former finance chief of postal services group Deutsche Post (DE:DPWGn), has been elected to replace Bjoerklund as chairman, the company said in a statement on Friday, without providing a reason for the departure.
Thermo Fisher last week walked away from its 11.3 billion euro ($13.30 billion) takeover deal after Qiagen’s earnings were boosted by coronavirus diagnostics, leaving its shareholders reluctant to cash out.
($1 = 0.8498 euros)
Qiagen chairman quits after Thermo Fisher’s takeover bid fails
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.